Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN115304568B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper-catalyzed asymmetric synthesis offers high ee values. Enhances supply chain reliability for chiral pharmaceutical intermediates. Cost reduction in API intermediate manufacturing.